Gastrointestinal


Last updated:
Total hit(s): 26
Select item(s)
Key Findings
Comments
(You can add your comments too!)
Original Article
(hover to see details)
Diarrhea and Abdominal pain were the only gastrointestinal symptoms with 5.9% prevalence each, out of 187 symptomatic cases.
33513332
(Emerg Infect Dis)
PMID
33513332
Date of Publishing: 2021 Mar
Title Epidemiology and Clinical Course of First Wave Coronavirus Disease Cases, Faroe Islands
Author(s) nameKristiansen MF, Heimustovu BH et al.
Journal Emerg Infect Dis
Impact factor
6.81
Citation count: 1


Gastrointestinal symptoms cluster was the third frequent cluster with 10% occurrence rate (16,518). Non-communicable diseases (Hypertension, Diabetes, Obesity) were more prevalent in symptomatic than presymptomatic cases. Presymptomatic carriers were observed in 13% (25,520) of the SARS-CoV-2 cases with no symptoms on test day and previous days. More common among older adults (31%) than children (26%).
33434668
(Int J Infect Dis)
PMID
33434668
Date of Publishing: 2021 Jan 9
Title Epidemiology of COVID-19 in Mexico: Symptomatic profiles and presymptomatic people
Author(s) nameFernández-Rojas MA, Luna-Ruiz Esparza MA et al.
Journal Int J Infect Dis
Impact factor
3.42
Citation count: 1


A case study of a 52 year old man with SARS-CoV-2 infection who developed vesicular skin eruptions and subsequent GI symptons but not any typical symptoms associated with COVID-19. The patient did not have any respiratory symptoms
33471878
(Cutis)
PMID
33471878
Date of Publishing: 2020 Dec
Title Skin eruption and gastrointestinal symptoms as presentation of COVID-19
Author(s) name Chu S, Christensen LF, Vidmar D.
Journal Cutis
Impact factor
0.47
Citation count: 1


28.6% of liver transplant recipients with COVID-19 presented diarrhea as a gastrointestinal symptom.
32891405
(Transplant Proc)
PMID
32891405
Date of Publishing: 2020 Nov
Title Clinical Presentation, Treatment, and Mortality Rate in Liver Transplant Recipients With Coronavirus Disease 2019: A Systematic Review and Quantitative Analysis
Author(s) nameFraser J, Mousley J et al.
Journal Transplant Proc
Impact factor
0.95
Citation count: 4


Most common gastrointestinal symptom was Sore throat (13.7%) and least common was Nausea (1.3%) out of 64 symptomatic cases.
33154280
(Niger Postgrad Med J)
PMID
33154280
Date of Publishing: 2020 Oct-Dec
Title Clinical characteristics, predictors of symptomatic coronavirus disease 2019 and duration of hospitalisation in a cohort of 632 Patients in Lagos State, Nigeria
Author(s) nameErinoso OA, Wright KO et al.
Journal Niger Postgrad Med J
Citation count 1


6 gastrointestinal symptoms were reported in 139 patients.
32077115
(Allergy)
PMID
32077115
Date of Publishing: 2020 Jul
Title Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Author(s) nameZhang JJ, Dong X et al.
Journal Allergy
Impact factor
8.7
Citation count: 898


Statistical analysis of patients with SARS-CoV-2 showing GI symptoms and fever, and infering the risk of severe illness and death. 1. The patients with fever and no GI symptoms were around 63.9%.
32606209
(Gut)
PMID
32606209
Date of Publishing: 2020 Jun 30
Title GI symptoms and fever increase the risk of severe illness and death in patients with COVID-19
Author(s) nameLiu J, Tao L et al.
Journal Gut
Impact factor
15.78
Citation count: 2


The entry of virus through angiotensin-converting enzyme 2 causes digestive symptoms. Patients detected with viral nucleic acid in the feces had longer recovery period as well as higher viral count. The study was performed at Union Hospital, Tongji Medical College (Wuhan, China)
32301761
(Am J Gastroenterol)
PMID
32301761
Date of Publishing: 2020 Jun
Title Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes
Author(s) nameHan C, Duan C et al.
Journal Am J Gastroenterol
Impact factor
6.73
Citation count: 110


A 68 year old man positive for SARS-CoV-2 experieced vomitting and fever, no other symptoms were reported. Epidemiologic history : Relative exposed to Wuhan Medical History: Over the counter antiemetic to ease vomitting Treatment: -interferon atomization inhalation (5 million U per time, Bid), oral lopinavir/ritonavir (2 capsules each time, Bid) and ribavirin 500 mg (intravenous infusion, Bid). Xuebijing (100 ml, Bid) + chinese herbs
32347435
(Dig Dis Sci)
PMID
32347435
Date of Publishing: 2020 Jun
Title SARSCoV2Induced Vomiting as Onset Symptom in a Patient with COVID19
Author(s) name Fu B, Qian K, Fu X.
Journal Dig Dis Sci
Impact factor
3.01
Citation count: 2


The paper reports that digestive system along with respiratory tract could be a potential route of infection. Hence some patients with SARS-CoV-2 infection might only exhibit Gastrointestinal symptoms without fever or respiratory manifestations. Epidemiologic history Close contact with infected person : 94 Environmental exposure : 99
32205220
(Clin Gastroenterol Hepatol)
PMID
32205220
Date of Publishing: 2020 Jun
Title Don't Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19)
Author(s) name Luo S, Zhang X, Xu H.
Journal Clin Gastroenterol Hepatol
Impact factor
5.3
Citation count: 89


About 254 patietnts with clinically confirmed Novel coronavirus-infected pneumonia (NCIP) were enrolled in order to study the frequency of GI symptoms in COVID-19 patients. Medical and non-medical staff were counted and analysed separately. As evidenced by our case report, this knowledge gap can lead to a delay in diagnosis and will increase the opportunity for viral transmission to other people including healthcare workers.
32199880
(Gastroenterology)
PMID
32199880
Date of Publishing: 2020 Jun
Title Effect of Gastrointestinal Symptoms in Patients With COVID-19
Author(s) nameZhou Z, Zhao N et al.
Journal Gastroenterology
Impact factor
15.13
Citation count: 55


A 22-yr-old COVID-19 positive man with a travel history to Wuhan had a 4-day history of diarrhoea (34 times a day) and fever (100.94 F) on admission. The patitent had a travel history to Wuhan,China.
32139552
(Gut)
PMID
32139552
Date of Publishing: 2020 Jun
Title SARS-CoV-2 induced diarrhoea as onset symptom in patient withCOVID-19
Author(s) nameSong Y, Liu P et al.
Journal Gut
Impact factor
15.78
Citation count: 87


Epidemiological, demographic, clinical and laboratory data of 95 cases with SARS-CoV-2 along with GI manifestations were analysed. 45 out of 58 had a travel history to Wuhan, China.
32241899
(Gut)
PMID
32241899
Date of Publishing: 2020 Jun
Title Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection
Author(s) nameLin L, Jiang X et al.
Journal Gut
Impact factor
15.78
Citation count: 186


A 22-yr-old COVID-19 positive man with a travel history to Wuhan had a 4-day history of diarrhoea (34 times a day) and fever (100.94 F) on admission. The patitent had a travel history to Wuhan,China.
32139552
(Gut)
PMID
32139552
Date of Publishing: 2020 Jun
Title SARS-CoV-2 induced diarrhoea as onset symptom in patient withCOVID-19
Author(s) nameSong Y, Liu P et al.
Journal Gut
Impact factor
15.78
Citation count: 87


A 68 year old man positive for SARS-CoV-2 experieced vomitting and fever, no other symptoms were reported. Epidemiologic history : Relative exposed to Wuhan Medical History: Over the counter antiemetic to ease vomitting Treatment: -interferon atomization inhalation (5 million U per time, Bid), oral lopinavir/ritonavir (2 capsules each time, Bid) and ribavirin 500 mg (intravenous infusion, Bid). Xuebijing (100 ml, Bid) + chinese herbs
32347435
(Dig Dis Sci)
PMID
32347435
Date of Publishing: 2020 Jun
Title SARSCoV2Induced Vomiting as Onset Symptom in a Patient with COVID19
Author(s) name Fu B, Qian K, Fu X.
Journal Dig Dis Sci
Impact factor
3.01
Citation count: 2


The paper reports that digestive system along with respiratory tract could be a potential route of infection. Hence some patients with SARS-CoV-2 infection might only exhibit Gastrointestinal symptoms without fever or respiratory manifestations. Epidemiologic history Close contact with infected person : 94 Environmental exposure : 99
32205220
(Clin Gastroenterol Hepatol)
PMID
32205220
Date of Publishing: 2020 Jun
Title Don't Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19)
Author(s) name Luo S, Zhang X, Xu H.
Journal Clin Gastroenterol Hepatol
Impact factor
5.3
Citation count: 89


About 254 patietnts with clinically confirmed Novel coronavirus-infected pneumonia (NCIP) were enrolled in order to study the frequency of GI symptoms in COVID-19 patients. Medical and non-medical staff were counted and analysed separately. As evidenced by our case report, this knowledge gap can lead to a delay in diagnosis and will increase the opportunity for viral transmission to other people including healthcare workers.
32199880
(Gastroenterology)
PMID
32199880
Date of Publishing: 2020 Jun
Title Effect of Gastrointestinal Symptoms in Patients With COVID-19
Author(s) nameZhou Z, Zhao N et al.
Journal Gastroenterology
Impact factor
15.13
Citation count: 55


Epidemiological, demographic, clinical and laboratory data of 95 cases with SARS-CoV-2 along with GI manifestations were analysed. 45 out of 58 had a travel history to Wuhan, China.
32241899
(Gut)
PMID
32241899
Date of Publishing: 2020 Jun
Title Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection
Author(s) nameLin L, Jiang X et al.
Journal Gut
Impact factor
15.78
Citation count: 186


A 74-yr-old COVID-19 positive man with a travel history to Scotland had a 3-day history of diarrhoea (3 times/day) and vomiting (3 times/day) prior to admission. There was no significant difference in the clinical outcomes (remained in hospital, discharged or died) between patients with and without GI symptoms. SARS-CoV-2 RNA could be detected in the oesophagus, stomach, duodenum and rectum in severe patients. Travel history to Scotland , 7 days prior to admission. past medical history of quiescent Ulcerative Colitis and Hypertension.
32429041
(Geriatrics (Basel))
PMID
32429041
Date of Publishing: 2020 May 15
Title COVID-19 and Gastrointestinal Symptoms-A Case Report
Author(s) name Mackett AJ, Keevil VL.
Journal Geriatrics (Basel)
Citation count 1


A 74-yr-old COVID-19 positive man with a travel history to Scotland had a 3-day history of diarrhoea (3 times/day) and vomiting (3 times/day) prior to admission. There was no significant difference in the clinical outcomes (remained in hospital, discharged or died) between patients with and without GI symptoms. SARS-CoV-2 RNA could be detected in the oesophagus, stomach, duodenum and rectum in severe patients. Travel history to Scotland , 7 days prior to admission. past medical history of quiescent Ulcerative Colitis and Hypertension.
32429041
(Geriatrics (Basel))
PMID
32429041
Date of Publishing: 2020 May 15
Title COVID-19 and Gastrointestinal Symptoms-A Case Report
Author(s) name Mackett AJ, Keevil VL.
Journal Geriatrics (Basel)
Citation count 1


The study found that apart from respiratory symptoms, digestive distress such as lack of appetite, Diarrhea, vomiting, abdominal pain are also the symptoms associated with COVID-19 disease. COVID-19 associated digestive symptoms were diagnosed at later stages due to lack of knowledge. The study was conducted on 3 heavily affected hospitals in Hubei province during the initial outbreak.
32287140
(Am J Gastroenterol)
PMID
32287140
Date of Publishing: 2020 May
Title Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study.
Author(s) namePan L, Mu M et al.
Journal Am J Gastroenterol
Impact factor
6.73
Citation count: 326


A case study of a 66 yr-old woman infected with an unsual SARS-CoV-2 infection, dominated by gastrointestinal symptoms. A two week travel history to Rome, Italy, and the symptoms appeared in a week after travel.
32250094
(Pol Arch Intern Med)
PMID
32250094
Date of Publishing: 2020 Apr 30
Title Gastrointestinal symptoms as the first, atypical indication of severe acute respiratory syndrome coronavirus 2 infection
Author(s) namePazgan-Simon M, Rorat M et al.
Journal Pol Arch Intern Med
Impact factor
3.007
Citation count: 2


Gastrointestinal symptoms such as Diarrhoea and Nausea was observed in 10% of patients whereas Vomiting and Abdominal pain was seen in 2-3%.
32031570
(JAMA)
PMID
32031570
Date of Publishing: 2020 Mar 17
Title Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Author(s) nameWang D, Hu B et al.
Journal JAMA
Impact factor
14.78
Citation count: 4868


Minor gastrointestinal symptoms such as Diarrhoea and Vomiting were reported in the patients.
32007143
(Lancet)
PMID
32007143
Date of Publishing: 2020 Feb 15
Title Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Author(s) nameChen N, Zhou M et al.
Journal Lancet
Impact factor
43.38
Citation count: 4234


Epidemiological, radiographic, clinical and laboratory data of 7 patients with SARS-CoV-2 along with GI manifestations were analysed. 1. The laboratory examination showed that all patients had increased C-reactive protein, accelerated erythrocyte sedimentation rate, hypoproteinemia, mild electrolyte disturbances. 2. Most patients also showed a lower count of white blood cells and lymphocytes. 3. Persistent lymphopenia was seen in severe patients.
32656221
(Front Med (Lausanne))
PMID
32656221
Date of Publishing: 2020
Title Clinical Characteristics of COVID-19 Patients With Gastrointestinal Symptoms: An Analysis of Seven Patients in China.
Author(s) nameAi JW, Zi H et al.
Journal Front Med (Lausanne)
Impact factor
3
Citation count: 4